Loading organizations...

Pomelo Health is a technology company.
Pomelo Care provides a virtual care platform for women's and children's health, spanning crucial life stages. Core programs include fertility, comprehensive prenatal and postpartum care, specialized pediatric and NICU assistance, and midlife health. The company offers personalized, accessible virtual support through dedicated nurse care partners and expert teams.
Marta Bralic Kerns founded Pomelo Care in 2021. Her experience in value-based care, coupled with personal pregnancy, highlighted critical deficiencies in U.S. maternal and infant healthcare. This insight prompted her to establish a virtual model designed to bridge systemic gaps, improve health outcomes, and enhance equitable access to specialized care.
Pomelo Care partners with payers, employers, and consultants, serving over 25 million covered lives across all fifty states, as well as individual patients. The company’s vision aims to elevate healthcare standards for women and children. It delivers accessible, evidence-based virtual solutions throughout their pivotal health journeys, striving for life-changing care.
Pomelo Health has raised $24.1M across 3 funding rounds.
Pomelo Health has raised $24.1M in total across 3 funding rounds.
Pomelo Health has raised $24.1M in total across 3 funding rounds.
Pomelo Health's investors include Eric Laflamme, Elodie Dupuy.
Pomelo Health / Pomelo Care — High-level profile and outlook.
High-level overview
Pomelo (often referenced as Pomelo Health for patient‑engagement/EMR add‑ons and Pomelo Care for the virtual maternal‑health business) is a healthcare technology and care‑delivery organization that builds digital patient engagement tools and a virtual, evidence‑based maternal and family care model. Pomelo’s patient‑engagement product set includes online booking, mobile check‑in, secure two‑way messaging, telemedicine, digital forms and appointment/queue management integrated with EMRs[1][3][4]. Pomelo Care operates a 24/7 hybrid virtual maternal and pediatric care model that pairs digital technology with community supports (e.g., doulas), and publishes peer‑reviewed outcomes showing reductions in cost, improved prenatal/postpartum visit timeliness, and better screening and treatment rates for perinatal conditions[2][5]. Growth signals include strategic commercial partnerships (e.g., TELUS distribution for the patient‑engagement product in Canada), venture investment including a16z leading a financing round for Pomelo Care, and multiple published outcome studies indicating scale and payer interest[3][5][2].
Origin story
Pomelo Health (the engagement/EMR add‑on) was founded around 2012 in Cambridge, Massachusetts to streamline clinic workflows and patient communications through a lightweight integration with practice EMRs[4]. Pomelo Care grew from clinician and technologist founders focused on maternal health; Marta Bralic Kerns (CEO) leads the company and framed Pomelo’s mission around closing maternal‑health access and quality gaps via a virtual care model supplemented by community supports[8][6]. The idea matured from clinical experience and data showing disparities in maternal outcomes; early pivotal moments include securing venture backing (including Andreessen Horowitz for Pomelo Care) and publishing peer‑reviewed studies that validated cost savings, reduced NICU/ER use, and improved preventive screening and treatment rates in pregnant populations[5][2].
Core differentiators
Role in the broader tech and healthcare landscape
Quick take & future outlook
Quick readback to the opening hook: Pomelo operates at two complementary intersections—practical EMR‑native patient engagement software (Pomelo Health) and an evidence‑driven hybrid virtual maternal and family care delivery business (Pomelo Care)—and its combination of technology, community supports, and peer‑reviewed outcomes is the core of its market differentiation[3][1][2].
If you’d like, I can:
Pomelo Health has raised $24.1M across 3 funding rounds. Most recently, it raised $5.0M Other Equity in October 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 14, 2020 | $5.0M Other Equity | Eric Laflamme | |
| Oct 1, 2019 | $15.1M Series B | Elodie Dupuy | |
| Jul 1, 2017 | $4.0M Series A |